FURTHER-STUDIES ON N-METHYL-1(3, 4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE AS A DISCRIMINATIVE STIMULUS - ANTAGONISM BY 5-HYDROXYTRYPTAMINE3 ANTAGONISTS

被引:23
作者
GLENNON, RA
HIGGS, R
YOUNG, R
ISSA, H
机构
[1] Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Richmond
关键词
MDMA; DRUG DISCRIMINATION; 5-HT2; 5-HT3; DOPAMINE; PIRENPERONE; ZACOPRIDE; LY278584; DOM; AMPHETAMINE;
D O I
10.1016/0091-3057(92)90488-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Using a standard two-lever operant paradigm, male Sprague-Dawley rats were trained to discriminate 1.5 mg/kg N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) from saline using a variable-interval 15-s schedule of reinforcement for food reward. Tests of stimulus antagonism were conducted to further define the mechanism of action of MDMA as a discriminative stimulus. Low doses of the 5-hydroxytryptamine(1A) (5-HT1A) antagonist NAN-190, the 5-HT2 antagonist pirenperone, and the dopamine antagonist haloperidol were able to somewhat attenuate the MDMA stimulus; however, none of these agents decreased MDMA-appropriate responding to less than 46%. The 5-HT3 antagonists zacopride and LY 278584 (ID50 = 0.02 mug/kg) antagonized the MDMA discriminative stimulus. Zacopride also attenuated the stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in DOM-trained animals but not those of (+)amphetamine in (+)amphetamine-trained animals. Several possible mechanistic interpretations are provided but it is concluded that MDMA produces its stimulus effects via a complex mechanism involving both dopaminergic and serotonergic components.
引用
收藏
页码:1099 / 1106
页数:8
相关论文
共 41 条
[1]  
BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
[2]   SPECTRAL AND INHIBITORY INTERACTIONS OF (+/-)-3,4-METHYLENEDIOXYAMPHETAMINE (MDA) AND (+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) WITH RAT HEPATIC MICROSOMES [J].
BRADY, JF ;
DISTEFANO, EW ;
CHO, AK .
LIFE SCIENCES, 1986, 39 (16) :1457-1464
[3]  
CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456
[4]   5-HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED PLACE-PREFERENCE CONDITIONING [J].
CARBONI, E ;
ACQUAS, E ;
LEONE, P ;
PEREZZANI, L ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) :159-160
[5]  
CHO AK, 1990, DRUG METAB DISPOS, V18, P686
[6]   THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS [J].
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) :181-202
[7]   DO FUNCTIONAL-RELATIONSHIPS EXIST BETWEEN 5-HT1A AND 5-HT2 RECEPTORS [J].
DARMANI, NA ;
MARTIN, BR ;
PANDEY, U ;
GLENNON, RA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) :901-906
[8]   PHARMACOLOGICAL CHARACTERIZATION OF EAR-SCRATCH RESPONSE IN MICE AS A BEHAVIORAL-MODEL FOR SELECTIVE 5-HT2-RECEPTOR AGONISTS AND EVIDENCE FOR 5-HT1B-RECEPTOR AND 5-HT2-RECEPTOR INTERACTIONS [J].
DARMANI, NA ;
MARTIN, BR ;
PANDEY, U ;
GLENNON, RA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (01) :95-99
[9]  
EDWARDS E, 1991, J PHARMACOL EXP THER, V256, P1025
[10]  
Finney D, 1952, PROBIT ANAL